Shares dropped 14% as investors signaled disappointment with the lack of clear outlook visibility and uneven sales momentum despite solid margin expansion and modest growth. The cautious tone on sales patterns and ongoing SG&A headwinds amid acquisition-related cost pressure weighed on confidence.

• Revenue rose 9.5% to $521.7 million, driven by a blend of organic growth and acquisitions, with sales per business day improving to $8.28 million.
• Gross margin expanded nearly 80 basis points to 32.3%, benefiting from pricing discipline and product mix shifts toward higher-value engineered solutions.
• Adjusted EBITDA margin came in at 11.1% with adjusted diluted EPS of $1.26; however, SG&A costs included discrete, one-time items linked to health care claims volatility and acquisition-related legal and audit expenses.
• Sales trends showed weakness early in the quarter (notably January), only partially offset by improvements in February and March, raising concerns about demand consistency.
• Segment performance was mixed: Innovative Pumping Solutions delivered strong 37.7% growth but lower-growth Service Centers (+3.3%) and Supply Chain Services (+2.7%) tempered overall results; Supply Chain still ramping new customer programs with gradual improvement expected.